188 related articles for article (PubMed ID: 28666100)
1. Augmented glioma-targeted theranostics using multifunctional polymer-coated carbon nanodots.
Wang S; Li C; Qian M; Jiang H; Shi W; Chen J; Lächelt U; Wagner E; Lu W; Wang Y; Huang R
Biomaterials; 2017 Oct; 141():29-39. PubMed ID: 28666100
[TBL] [Abstract][Full Text] [Related]
2. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional mesoporous silica-coated graphene nanosheet used for chemo-photothermal synergistic targeted therapy of glioma.
Wang Y; Wang K; Zhao J; Liu X; Bu J; Yan X; Huang R
J Am Chem Soc; 2013 Mar; 135(12):4799-804. PubMed ID: 23495667
[TBL] [Abstract][Full Text] [Related]
4. A novel peptide-drug conjugate for glioma-targeted drug delivery.
Zhou J; Meng N; Lu L; Lu J; Wu S; Ding Y; Wu S; Bao Y; Xu Q; Chen R; Wang J; Xie C; Wu J; Lu W
J Control Release; 2024 May; 369():722-733. PubMed ID: 38583575
[TBL] [Abstract][Full Text] [Related]
5. Apoferritin Nanocage for Brain Targeted Doxorubicin Delivery.
Chen Z; Zhai M; Xie X; Zhang Y; Ma S; Li Z; Yu F; Zhao B; Zhang M; Yang Y; Mei X
Mol Pharm; 2017 Sep; 14(9):3087-3097. PubMed ID: 28728419
[TBL] [Abstract][Full Text] [Related]
6. Localised delivery of doxorubicin to prostate cancer cells through a PSMA-targeted hyperbranched polymer theranostic.
Pearce AK; Simpson JD; Fletcher NL; Houston ZH; Fuchs AV; Russell PJ; Whittaker AK; Thurecht KJ
Biomaterials; 2017 Oct; 141():330-339. PubMed ID: 28711780
[TBL] [Abstract][Full Text] [Related]
7. Synergistic Combination of Doxorubicin and Paclitaxel Delivered by Blood Brain Barrier and Glioma Cells Dual Targeting Liposomes for Chemotherapy of Brain Glioma.
Chen X; Yuan M; Zhang Q; Ting Yang Y; Gao H; He Q
Curr Pharm Biotechnol; 2016; 17(7):636-50. PubMed ID: 27033513
[TBL] [Abstract][Full Text] [Related]
8. Liposome-based glioma targeted drug delivery enabled by stable peptide ligands.
Wei X; Gao J; Zhan C; Xie C; Chai Z; Ran D; Ying M; Zheng P; Lu W
J Control Release; 2015 Nov; 218():13-21. PubMed ID: 26428462
[TBL] [Abstract][Full Text] [Related]
9. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
[TBL] [Abstract][Full Text] [Related]
10. Penetration of blood-brain barrier and antitumor activity and nerve repair in glioma by doxorubicin-loaded monosialoganglioside micelles system.
Zou D; Wang W; Lei D; Yin Y; Ren P; Chen J; Yin T; Wang B; Wang G; Wang Y
Int J Nanomedicine; 2017; 12():4879-4889. PubMed ID: 28744122
[TBL] [Abstract][Full Text] [Related]
11. Tumor-specific pH-responsive peptide-modified pH-sensitive liposomes containing doxorubicin for enhancing glioma targeting and anti-tumor activity.
Zhao Y; Ren W; Zhong T; Zhang S; Huang D; Guo Y; Yao X; Wang C; Zhang WQ; Zhang X; Zhang Q
J Control Release; 2016 Jan; 222():56-66. PubMed ID: 26682502
[TBL] [Abstract][Full Text] [Related]
12. Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals.
Zong T; Mei L; Gao H; Cai W; Zhu P; Shi K; Chen J; Wang Y; Gao F; He Q
Mol Pharm; 2014 Jul; 11(7):2346-57. PubMed ID: 24893333
[TBL] [Abstract][Full Text] [Related]
13. A d-Peptide Ligand of Integrins for Simultaneously Targeting Angiogenic Blood Vasculature and Glioma Cells.
Ren Y; Zhan C; Gao J; Zhang M; Wei X; Ying M; Liu Z; Lu W
Mol Pharm; 2018 Feb; 15(2):592-601. PubMed ID: 29283582
[TBL] [Abstract][Full Text] [Related]
14. Enhancing tumor penetration and targeting using size-minimized and zwitterionic nanomedicines.
Zhang Y; Chen W; Yang C; Fan Q; Wu W; Jiang X
J Control Release; 2016 Sep; 237():115-24. PubMed ID: 27397491
[No Abstract] [Full Text] [Related]
15. Lactoferrin modified doxorubicin-loaded procationic liposomes for the treatment of gliomas.
Chen H; Qin Y; Zhang Q; Jiang W; Tang L; Liu J; He Q
Eur J Pharm Sci; 2011 Sep; 44(1-2):164-73. PubMed ID: 21782939
[TBL] [Abstract][Full Text] [Related]
16. Integrated self-assembling drug delivery system possessing dual responsive and active targeting for orthotopic ovarian cancer theranostics.
Lin CJ; Kuan CH; Wang LW; Wu HC; Chen Y; Chang CW; Huang RY; Wang TW
Biomaterials; 2016 Jun; 90():12-26. PubMed ID: 26974704
[TBL] [Abstract][Full Text] [Related]
17. Turn-on theranostic fluorescent nanoprobe by electrostatic self-assembly of carbon dots with doxorubicin for targeted cancer cell imaging, in vivo hyaluronidase analysis, and targeted drug delivery.
Gao N; Yang W; Nie H; Gong Y; Jing J; Gao L; Zhang X
Biosens Bioelectron; 2017 Oct; 96():300-307. PubMed ID: 28511113
[TBL] [Abstract][Full Text] [Related]
18. Modular approach for theranostic polymer conjugates with activatable fluorescence: Impact of linker design on the stimuli-induced release of doxorubicin.
Nagel G; Tschiche HR; Wedepohl S; Calderón M
J Control Release; 2018 Sep; 285():200-211. PubMed ID: 30005907
[TBL] [Abstract][Full Text] [Related]
19. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V
Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS
J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]